Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events by Kevin E. Boczar, MD, Rob Beanlands, MD, George Wells, Doug Coyle

Get full text

Cost-Effectiveness of Canakinumab From a Canadian Perspective for Recurrent Cardiovascular Events by Kevin E. Boczar, MD, Rob Beanlands, MD, George Wells, PhD, Doug Coyle, PhD

Get full text

Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial by Pietro Di Santo, Rebecca Mathew, Richard G. Jung, Trevor Simard, Stephanie Skanes, Brennan Mao, F. Daniel Ramirez, Jeffrey A. Marbach, Omar Abdel-Razek, Pouya Motazedian, Simon Parlow, Kevin E. Boczar, Gianni D’Egidio, Steven Hawken, Jordan Bernick, George A. Wells, Alexander Dick, Derek Y. So, Christopher Glover, Juan J. Russo, Caroline McGuinty, Benjamin Hibbert, the CAPITAL DOREMI investigators

Get full text